Contracts › 75F40124C00097
75F40124C00097: Direct 8(A) Award of (1) 12-MONTH Base Period and (4) 12-MONTH Option Periods, Time & Materials (T&M) Type Contract to Kaiva Strategies, Llc for Professional Services to Support Fda Office of Women's Health Science Related Activities, of
Awarded to Kaiva Strategies, Llc by Food and Drug Administration (FDA).
$1.9Mobligated
$3.1Mpotential value
10 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40124C00097 |
|---|---|
| Awardee | Kaiva Strategies, Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541690 Other Scientific and Technical Consulting Services |
| PSC | R425 Support- Professional: Engineering/Technical |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 27 August 2024 to 10 August 2027 |
| Potential end | 22 May 2029 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541690 contracts · All expiring contracts · USASpending record